Fig. 7
From: Cross talk of tumor protein D52 (TPD52) with KLF9, PKCε, and MicroRNA 223 in ovarian cancer
Specificity of miR-223 and target genes TPD52, KLF9, and PKCε expression in ovarian cancer diagnosis. Receiver operating characteristic (ROC) curve analysis for miR-223, TPD52, KLF9, and PKCe predicted elevated risk of ovarian cancer cancer. (A) TPD52 AUC = 0.7769; 95% CI = 0.7100– 0.8438. (B) KLF9 AUC = 0.5608; 95% CI = 0.4652–0.6564. (C) miR-223 AUC = 0.7915; 95% CI = 0.7213– 0.8617. (D) PKCε AUC = 0.7630; 95% CI = 0.6883–0.8377.